论文部分内容阅读
目的分析川芎嗪对脑梗塞的疗效。方法将脑梗塞患者分成2组,观察组为1260例,每天静脉滴注川芎嗪400mg;对照组为200例,每天静滴120mg川芎嗪,每疗程21天。结果川芎嗪的临床效果和血液粘度改变两组之间有显著性差异(P<0.01)。观察组的临床效果和血液粘度的改善比治疗组好。结论大剂量川芎嗪治疗脑梗塞可获得显著的临床效果,并无任何副反应,值得临床推广
Objective To analyze the curative effect of ligustrazine on cerebral infarction. Methods The patients with cerebral infarction were divided into two groups, the observation group was 1260 cases, intravenous infusion of ligustrazine 400 mg daily; control group 200 cases, intravenous infusion of 120 mg ligustrazine for 21 days. Results The clinical effects of Ligustrazine and blood viscosity changes were significantly different between the two groups (P <0.01). The observation group’s clinical effect and blood viscosity improvement better than the treatment group. Conclusion High doses of ligustrazine in the treatment of cerebral infarction can obtain a significant clinical effect, without any side effects, it is worth clinical promotion